Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone Vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The Viable Phase 3 Randomized Clinical Trial

AuthID
P-00W-604
26
Author(s)
Vogelzang, NJ
·
Beer, TM
·
Gerritsen, W
·
Oudard, S
·
Wiechno, P
·
Kukielka Budny, B
·
Samal, V
·
Hajek, J
·
Feyerabend, S
·
Khoo, V
·
[+6]·
Hussain, A
·
Bahl, A
·
Hussain, S
·
Fricke, H
·
Kadlecova, P
·
Scheiner, T
·
Korolkiewicz, RP
·
Bartunkova, J
·
Spisek, R
1
Group Author(s)
VIABLE Investigators
Document Type
Article in Press
Year published
2022
Published
in JAMA ONCOLOGY, ISSN: 2374-2437
Volume: 8, Issue: 4, Pages: 546 (7)
Indexing
Publication Identifiers
Pubmed: 35142815
SCOPUS: 2-s2.0-85125043224
Wos: WOS:000754028300007
Source Identifiers
ISSN: 2374-2437
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Vogelzang, NJ;   2 Beer, TM;   3 Gerritsen, W;
4 Oudard, S;   5 Wiechno, P;   6 Kukielka Budny, B;
7 Samal, V;   8 Hajek, J;   9 Feyerabend, S;
10 Khoo, V;   11 Stenzl, A;   12 Csoszi, T;
13 Filipovic, Z;   14 Goncalves, F;   15 Prokhorov, A;
16 Cheung, E;   17 Hussain, A;   18 Sousa, N ;
19 Bahl, A;   20 Hussain, S;   21 Fricke, H;
22 Kadlecova, P;   23 Scheiner, T;   24 Korolkiewicz, RP;
25 Bartunkova, J;   26 Spisek, R;